8-K: Select Medical Subsidiary Concentra Announces Estimated Q2 2024 Financial Results

Select Medical Holdings Corporation has released estimated financial results for its subsidiary Concentra for the second quarter of 2024, ahead of the company's full earnings announcement.

Summary

• Select Medical has provided an estimate of Concentra's financial performance for the second quarter of 2024.
• Concentra's net operating revenue is estimated to be approximately $477.9 million.
• Income from operations for Concentra is estimated at approximately $83.9 million.
• These estimates are based on currently available information and are subject to change upon completion of Select Medical's financial closing procedures.
• The actual results may differ from these preliminary estimates.
• Select Medical will host a conference call on August 2, 2024, to discuss its second quarter results and business outlook.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive as the estimated results show growth compared to the previous year, but the document also includes cautionary language about the preliminary nature of the results and various risks.

Positives

• Concentra's estimated revenue for Q2 2024 is higher than the actual revenue for Q2 2023 ($477.9 million vs $467.1 million).
• Concentra's estimated income from operations for Q2 2024 is higher than the actual income from operations for Q2 2023 ($83.9 million vs $82.1 million).
• The number of onsite health clinics operated increased from 141 in Q2 2023 to 154 in Q2 2024.
• Revenue per visit for Workers Compensation increased from $194.92 in Q2 2023 to $198.18 in Q2 2024.

Negatives

• The total number of patient visits decreased from 3,267,894 in Q2 2023 to 3,214,255 in Q2 2024.
• The number of visits per day for Employer Services decreased from 27,828 in Q2 2023 to 26,600 in Q2 2024.

Risks

• The estimated financial results are subject to change upon completion of Select Medical's financial closing procedures.
• Actual results may differ materially from the preliminary estimates.
• The company faces risks related to work-related injuries, regulatory changes, labor shortages, competition, and security breaches.
• There are risks associated with acquisitions, reliance on third parties, and compliance with healthcare laws.
• The company is exposed to risks from economic conditions, geopolitical tensions, and public health threats.

Future Outlook

Select Medical will host a conference call on August 2, 2024, to discuss its second quarter results and business outlook.

Management Comments

• The expectations regarding Concentra's financial results for the second quarter of 2024 are management estimates based on currently available information.
• These estimates are subject to change upon completion of Select Medical's financial statement closing procedures.

Industry Context

This announcement provides an early look at the performance of Select Medical's occupational health segment, Concentra, which is a key part of their business. The results will be closely watched by investors and analysts in the healthcare services sector.

Comparison to Industry Standards

• The revenue per visit for Concentra's Workers Compensation segment at $198.18 is a key metric to compare against other occupational health providers such as U.S. HealthWorks (owned by Optum) and Occucare International.
• The total patient visits of 3,214,255 can be benchmarked against similar large-scale occupational health networks to assess market share and operational efficiency.
• The income from operations of $83.9 million should be compared to the profitability of other healthcare service providers with similar business models, such as those in the outpatient rehabilitation and urgent care sectors.

Stakeholder Impact

• Shareholders will be interested in the financial performance of Concentra as it is a significant part of Select Medical's business.
• Employees may be impacted by any changes in the company's performance or strategy.
• Customers and partners will be interested in the company's ability to provide quality services.

Next Steps

• Select Medical will complete its financial statement closing procedures.
• Select Medical will announce its full second quarter results on August 1, 2024.
• Select Medical will host a conference call on August 2, 2024, to discuss its results and business outlook.

Key Dates

Keywords

Concentra, Select Medical, Occupational Health, Financial Results, Revenue, Income from Operations, Healthcare, Q2 2024, Earnings, Patient Visits